Metabolite Biomarkers of Leishmania Antimony Resistance

ABSTRACT: Leishmania parasites cause leishmaniasis, one of the most epidemiologically important neglected tropical diseases. Leishmania exhibits a high ability of developing drug resistance, and drug resistance is one of the main threats to public health, as it is associated with increased incidence...

Full description

Autores:
Galeano Jaramillo, Elkin de Jesús
Muskus López, Carlos Enrique
Gutiérrez Guarnizo, Sneider Alexander
Karamysheva, Zemfira N.
Tipo de recurso:
Article of investigation
Fecha de publicación:
2021
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/38985
Acceso en línea:
https://hdl.handle.net/10495/38985
Palabra clave:
Antimonio - toxicidad
Antimony - toxicity
Antiprotozoarios - toxicidad
Antiprotozoal Agents - toxicity
Resistencia a Medicamentos
Drug Resistance
Metabolismo Energético
Energy Metabolism
Leishmania tropica - efectos de los fármacos
Leishmania tropica - drug effects
Leishmania tropica - metabolismo
Leishmania tropica - metabolism
Metaboloma
Metabolome
Presión Osmótica
Osmotic Pressure
Estrés Oxidativo
Oxidative Stress
https://id.nlm.nih.gov/mesh/D000965
https://id.nlm.nih.gov/mesh/D000981
https://id.nlm.nih.gov/mesh/D004351
https://id.nlm.nih.gov/mesh/D004734
https://id.nlm.nih.gov/mesh/D007895
https://id.nlm.nih.gov/mesh/D055442
https://id.nlm.nih.gov/mesh/D009997
https://id.nlm.nih.gov/mesh/D018384
Rights
openAccess
License
https://creativecommons.org/licenses/by/4.0/
id UDEA2_1e5cbd29aced8d942b37464436da2877
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/38985
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Metabolite Biomarkers of Leishmania Antimony Resistance
title Metabolite Biomarkers of Leishmania Antimony Resistance
spellingShingle Metabolite Biomarkers of Leishmania Antimony Resistance
Antimonio - toxicidad
Antimony - toxicity
Antiprotozoarios - toxicidad
Antiprotozoal Agents - toxicity
Resistencia a Medicamentos
Drug Resistance
Metabolismo Energético
Energy Metabolism
Leishmania tropica - efectos de los fármacos
Leishmania tropica - drug effects
Leishmania tropica - metabolismo
Leishmania tropica - metabolism
Metaboloma
Metabolome
Presión Osmótica
Osmotic Pressure
Estrés Oxidativo
Oxidative Stress
https://id.nlm.nih.gov/mesh/D000965
https://id.nlm.nih.gov/mesh/D000981
https://id.nlm.nih.gov/mesh/D004351
https://id.nlm.nih.gov/mesh/D004734
https://id.nlm.nih.gov/mesh/D007895
https://id.nlm.nih.gov/mesh/D055442
https://id.nlm.nih.gov/mesh/D009997
https://id.nlm.nih.gov/mesh/D018384
title_short Metabolite Biomarkers of Leishmania Antimony Resistance
title_full Metabolite Biomarkers of Leishmania Antimony Resistance
title_fullStr Metabolite Biomarkers of Leishmania Antimony Resistance
title_full_unstemmed Metabolite Biomarkers of Leishmania Antimony Resistance
title_sort Metabolite Biomarkers of Leishmania Antimony Resistance
dc.creator.fl_str_mv Galeano Jaramillo, Elkin de Jesús
Muskus López, Carlos Enrique
Gutiérrez Guarnizo, Sneider Alexander
Karamysheva, Zemfira N.
dc.contributor.author.none.fl_str_mv Galeano Jaramillo, Elkin de Jesús
Muskus López, Carlos Enrique
Gutiérrez Guarnizo, Sneider Alexander
Karamysheva, Zemfira N.
dc.contributor.researchgroup.spa.fl_str_mv Grupo de Investigación en Sustancias Bioactivas (GISB)
Programa de Estudio y Control de Enfermedades Tropicales (PECET)
dc.subject.decs.none.fl_str_mv Antimonio - toxicidad
Antimony - toxicity
Antiprotozoarios - toxicidad
Antiprotozoal Agents - toxicity
Resistencia a Medicamentos
Drug Resistance
Metabolismo Energético
Energy Metabolism
Leishmania tropica - efectos de los fármacos
Leishmania tropica - drug effects
Leishmania tropica - metabolismo
Leishmania tropica - metabolism
Metaboloma
Metabolome
Presión Osmótica
Osmotic Pressure
Estrés Oxidativo
Oxidative Stress
topic Antimonio - toxicidad
Antimony - toxicity
Antiprotozoarios - toxicidad
Antiprotozoal Agents - toxicity
Resistencia a Medicamentos
Drug Resistance
Metabolismo Energético
Energy Metabolism
Leishmania tropica - efectos de los fármacos
Leishmania tropica - drug effects
Leishmania tropica - metabolismo
Leishmania tropica - metabolism
Metaboloma
Metabolome
Presión Osmótica
Osmotic Pressure
Estrés Oxidativo
Oxidative Stress
https://id.nlm.nih.gov/mesh/D000965
https://id.nlm.nih.gov/mesh/D000981
https://id.nlm.nih.gov/mesh/D004351
https://id.nlm.nih.gov/mesh/D004734
https://id.nlm.nih.gov/mesh/D007895
https://id.nlm.nih.gov/mesh/D055442
https://id.nlm.nih.gov/mesh/D009997
https://id.nlm.nih.gov/mesh/D018384
dc.subject.meshuri.none.fl_str_mv https://id.nlm.nih.gov/mesh/D000965
https://id.nlm.nih.gov/mesh/D000981
https://id.nlm.nih.gov/mesh/D004351
https://id.nlm.nih.gov/mesh/D004734
https://id.nlm.nih.gov/mesh/D007895
https://id.nlm.nih.gov/mesh/D055442
https://id.nlm.nih.gov/mesh/D009997
https://id.nlm.nih.gov/mesh/D018384
description ABSTRACT: Leishmania parasites cause leishmaniasis, one of the most epidemiologically important neglected tropical diseases. Leishmania exhibits a high ability of developing drug resistance, and drug resistance is one of the main threats to public health, as it is associated with increased incidence, mortality, and healthcare costs. The antimonial drug is the main historically implemented drug for leishmaniasis. Nevertheless, even though antimony resistance has been widely documented, the mechanisms involved are not completely understood. In this study, we aimed to identify potential metabolite biomarkers of antimony resistance that could improve leishmaniasis treatment. Here, using L. tropica promastigotes as the biological model, we showed that the level of response to antimony can be potentially predicted using 1H-NMR-based metabolomic profiling. Antimonyresistant parasites exhibited differences in metabolite composition at the intracellular and extracellular levels, suggesting that a metabolic remodeling is required to combat the drug. Simple and timesaving exometabolomic analysis can be efficiently used for the differentiation of sensitive and resistant parasites. Our findings suggest that changes in metabolite composition are associated with an optimized response to the osmotic/oxidative stress and a rearrangement of carbon-energy metabolism. The activation of energy metabolism can be linked to the high energy requirement during the antioxidant stress response. We also found that metabolites such as proline and lactate change linearly with the level of resistance to antimony, showing a close relationship with the parasite’s efficiency of drug resistance. A list of potential metabolite biomarkers is described and discussed.
publishDate 2021
dc.date.issued.none.fl_str_mv 2021
dc.date.accessioned.none.fl_str_mv 2024-04-11T03:06:57Z
dc.date.available.none.fl_str_mv 2024-04-11T03:06:57Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Gutierrez Guarnizo, S.A.; Karamysheva, Z.N.; Galeano, E.; Muskus, C.E. Metabolite Biomarkers of Leishmania Antimony Resistance. Cells 2021, 10, 1063. https://doi.org/10.3390/cells10051063
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/38985
dc.identifier.doi.none.fl_str_mv 10.3390/cells10051063
dc.identifier.eissn.none.fl_str_mv 2073-4409
identifier_str_mv Gutierrez Guarnizo, S.A.; Karamysheva, Z.N.; Galeano, E.; Muskus, C.E. Metabolite Biomarkers of Leishmania Antimony Resistance. Cells 2021, 10, 1063. https://doi.org/10.3390/cells10051063
10.3390/cells10051063
2073-4409
url https://hdl.handle.net/10495/38985
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Cells
dc.relation.citationendpage.spa.fl_str_mv 1079
dc.relation.citationissue.spa.fl_str_mv 5
dc.relation.citationstartpage.spa.fl_str_mv 1063
dc.relation.citationvolume.spa.fl_str_mv 10
dc.relation.ispartofjournal.spa.fl_str_mv Cells
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by/4.0/
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by/2.5/co/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
http://creativecommons.org/licenses/by/2.5/co/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 19 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf - application/epub
dc.publisher.spa.fl_str_mv MDPI
dc.publisher.place.spa.fl_str_mv Basilea, Suiza
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/7281376b-f984-4f56-98f6-7fc823de5ce5/download
https://bibliotecadigital.udea.edu.co/bitstreams/ebbf8a2c-f192-47ed-a5a6-4f9ef5e287a4/download
https://bibliotecadigital.udea.edu.co/bitstreams/2269ae19-66de-45fc-b0f8-161c7c9c72b1/download
https://bibliotecadigital.udea.edu.co/bitstreams/b5ad2e63-5f88-43d3-89da-efc2ea4f2c76/download
https://bibliotecadigital.udea.edu.co/bitstreams/daf74e4a-0f84-4e18-8b3f-cd66a6ad7f3d/download
https://bibliotecadigital.udea.edu.co/bitstreams/ce1f6272-1f10-4500-b481-a163630275e4/download
bitstream.checksum.fl_str_mv 7064fb3e67db90e611b2d1078ed0bdaa
c55bc8495a27b6a5ebfa51315a5687c4
1646d1f6b96dbbbc38035efc9239ac9c
8a4605be74aa9ea9d79846c1fba20a33
9797a422ab1e1290272156dc9e6e868a
46ae52ed9b3e72769bc918b6864a98d4
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052435910426624
spelling Galeano Jaramillo, Elkin de JesúsMuskus López, Carlos EnriqueGutiérrez Guarnizo, Sneider AlexanderKaramysheva, Zemfira N.Grupo de Investigación en Sustancias Bioactivas (GISB)Programa de Estudio y Control de Enfermedades Tropicales (PECET)2024-04-11T03:06:57Z2024-04-11T03:06:57Z2021Gutierrez Guarnizo, S.A.; Karamysheva, Z.N.; Galeano, E.; Muskus, C.E. Metabolite Biomarkers of Leishmania Antimony Resistance. Cells 2021, 10, 1063. https://doi.org/10.3390/cells10051063https://hdl.handle.net/10495/3898510.3390/cells100510632073-4409ABSTRACT: Leishmania parasites cause leishmaniasis, one of the most epidemiologically important neglected tropical diseases. Leishmania exhibits a high ability of developing drug resistance, and drug resistance is one of the main threats to public health, as it is associated with increased incidence, mortality, and healthcare costs. The antimonial drug is the main historically implemented drug for leishmaniasis. Nevertheless, even though antimony resistance has been widely documented, the mechanisms involved are not completely understood. In this study, we aimed to identify potential metabolite biomarkers of antimony resistance that could improve leishmaniasis treatment. Here, using L. tropica promastigotes as the biological model, we showed that the level of response to antimony can be potentially predicted using 1H-NMR-based metabolomic profiling. Antimonyresistant parasites exhibited differences in metabolite composition at the intracellular and extracellular levels, suggesting that a metabolic remodeling is required to combat the drug. Simple and timesaving exometabolomic analysis can be efficiently used for the differentiation of sensitive and resistant parasites. Our findings suggest that changes in metabolite composition are associated with an optimized response to the osmotic/oxidative stress and a rearrangement of carbon-energy metabolism. The activation of energy metabolism can be linked to the high energy requirement during the antioxidant stress response. We also found that metabolites such as proline and lactate change linearly with the level of resistance to antimony, showing a close relationship with the parasite’s efficiency of drug resistance. A list of potential metabolite biomarkers is described and discussed.Colombia. Ministerio de Ciencia, Tecnología e Innovación - MincienciasGobernación del TolimaCOL0010359COL001509919 páginasapplication/pdf - application/epubengMDPIBasilea, Suizahttps://creativecommons.org/licenses/by/4.0/http://creativecommons.org/licenses/by/2.5/co/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Metabolite Biomarkers of Leishmania Antimony ResistanceArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAntimonio - toxicidadAntimony - toxicityAntiprotozoarios - toxicidadAntiprotozoal Agents - toxicityResistencia a MedicamentosDrug ResistanceMetabolismo EnergéticoEnergy MetabolismLeishmania tropica - efectos de los fármacosLeishmania tropica - drug effectsLeishmania tropica - metabolismoLeishmania tropica - metabolismMetabolomaMetabolomePresión OsmóticaOsmotic PressureEstrés OxidativoOxidative Stresshttps://id.nlm.nih.gov/mesh/D000965https://id.nlm.nih.gov/mesh/D000981https://id.nlm.nih.gov/mesh/D004351https://id.nlm.nih.gov/mesh/D004734https://id.nlm.nih.gov/mesh/D007895https://id.nlm.nih.gov/mesh/D055442https://id.nlm.nih.gov/mesh/D009997https://id.nlm.nih.gov/mesh/D018384Cells10795106310Cells755-2016RoR:03fd5ne08PublicationORIGINALGaleanoElkin_2021_Metabolite_Biomarkers_Leishmania_Antimony_Resistance.pdfGaleanoElkin_2021_Metabolite_Biomarkers_Leishmania_Antimony_Resistance.pdfArtículo de investigaciónapplication/pdf3205882https://bibliotecadigital.udea.edu.co/bitstreams/7281376b-f984-4f56-98f6-7fc823de5ce5/download7064fb3e67db90e611b2d1078ed0bdaaMD51trueAnonymousREADGaleanoElkin_2021_Metabolite_Biomarkers_Leishmania_Antimony_Resistance.epubGaleanoElkin_2021_Metabolite_Biomarkers_Leishmania_Antimony_Resistance.epubArtículo de investigaciónapplication/epub+zip8745253https://bibliotecadigital.udea.edu.co/bitstreams/ebbf8a2c-f192-47ed-a5a6-4f9ef5e287a4/downloadc55bc8495a27b6a5ebfa51315a5687c4MD52falseAnonymousREADCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8927https://bibliotecadigital.udea.edu.co/bitstreams/2269ae19-66de-45fc-b0f8-161c7c9c72b1/download1646d1f6b96dbbbc38035efc9239ac9cMD53falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/b5ad2e63-5f88-43d3-89da-efc2ea4f2c76/download8a4605be74aa9ea9d79846c1fba20a33MD54falseAnonymousREADTEXTGaleanoElkin_2021_Metabolite_Biomarkers_Leishmania_Antimony_Resistance.pdf.txtGaleanoElkin_2021_Metabolite_Biomarkers_Leishmania_Antimony_Resistance.pdf.txtExtracted texttext/plain97795https://bibliotecadigital.udea.edu.co/bitstreams/daf74e4a-0f84-4e18-8b3f-cd66a6ad7f3d/download9797a422ab1e1290272156dc9e6e868aMD55falseAnonymousREADTHUMBNAILGaleanoElkin_2021_Metabolite_Biomarkers_Leishmania_Antimony_Resistance.pdf.jpgGaleanoElkin_2021_Metabolite_Biomarkers_Leishmania_Antimony_Resistance.pdf.jpgGenerated Thumbnailimage/jpeg14852https://bibliotecadigital.udea.edu.co/bitstreams/ce1f6272-1f10-4500-b481-a163630275e4/download46ae52ed9b3e72769bc918b6864a98d4MD56falseAnonymousREAD10495/38985oai:bibliotecadigital.udea.edu.co:10495/389852025-03-26 22:18:59.059https://creativecommons.org/licenses/by/4.0/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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